Graves' disease and hyperthyroidism: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• PD-1 0
• PD-L1 0
• SGLT2 0
• TP53 0
• BRAF 0
• CTLA-4 0
• EGFR 0
• FTO 0
• GLP-1 0
• PCSK9 0
• RAS 0
• TERT 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 521 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Suspended

  Personalized Treatment in Thyroid Disorders

  NCT03517579· Johns Hopkins University· Updated 22 Oct 2026

  “Funding issues”Registry text, quoted unchanged. Source

• Terminated

  Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

  NCT05678374· Vastra Gotaland Region· Updated 14 Sept 2026

  “We had initially planned to include 60 participants per group. However, due to substantial difficulties with participant recruitment, we decided to close the study after enrolling 39, 15, and 40 participants in the respective groups.”Registry text, quoted unchanged. Source

• Withdrawn

  The Sequestration of Holistic Stress Management Techniques for Adults

  NCT06098755· Goddess Zena I. Jones· Updated 4 Feb 2026

  “No Participants Enrolled”Registry text, quoted unchanged. Source

• Withdrawn

  Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery

  NCT05774535· Istituto Auxologico Italiano· Updated 2 Oct 2025

  “No enrollment”Registry text, quoted unchanged. Source

• Terminated

  Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules

  NCT05142904· Rijnstate Hospital· Updated 17 Jul 2025

  “Switched from RCT to observational prospective cohort due to termination of subsidy (delay due to insufficient inclusion-rate). Follow-up of RCT-arm will be completed. Patients can still be included in a observational cohort.”Registry text, quoted unchanged. Source

• Suspended

  Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz

  NCT06240455· Worg Biotherapeutics Inc.· Updated 8 May 2025

  “Not feasible to recruit suitable subjects”Registry text, quoted unchanged. Source

• Terminated

  Efficacy of Methimazole Dosing Algorithm

  NCT05964452· Cook County Health· Updated 27 Dec 2024

  “Unable to reach recruiting goals”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

  NCT07722546· Biogen· Source

• Hydroxychloroquine in Mild Graves' Orbitopathy

  NCT05126147· National Taiwan University Hospital· Source

• A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

  NCT06984627· Sanofi· Source

• Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

  NCT07369063· Northwell Health· Source

• Thyroid-Stimulating Hormone Receptor (TSHR) Blockade With REGN24493 in Adult Participants With Graves' Disease (GD)

  NCT07861152· Regeneron Pharmaceuticals· Source

• Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' Disease

  NCT07164079· Betul Uner· Source

• In Vivo CAR-T for Refractory Graves' Disease

  NCT07333677· Shanghai Zhongshan Hospital· Source

• A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment

  NCT07405320· University of Auckland, New Zealand· Source

• Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter

  NCT04856488· Jan Calissendorff· Source

• Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients With Graves Disease

  NCT07332988· Grigore T. Popa University of Medicine and Pharmacy· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 3
• Organoids 1
• Mendelian Randomization Analysis 29
• CRISPR-Cas Systems 1
• Gene Expression Profiling 14
• Sequence Analysis, RNA 2
• Proteomics 3
• Metabolomics 9
• Mass Spectrometry 5
• Flow Cytometry 3
• Immunohistochemistry 7
• Positron-Emission Tomography 2
• Magnetic Resonance Imaging 49
• Machine Learning 15
• Deep Learning 5
• Cohort Studies 69
• Genome-Wide Association Study 25

• Tear Metabolomics in Thyroid Eye Disease: Molecular Signatures, Disease Activity, and Therapeutic Implications.

  Int Ophthalmol Clin, Sept 2026

• Identification of key genes and metabolites in thyroid eye disease through integrated transcriptomic and metabolomic analysis.

  Front Endocrinol (Lausanne), Sept 2026

• Differential analysis of gut microbiota and metabolites in patients with Graves' disease and combined Helicobacter pylori infection.

  BMC Endocr Disord, Aug 2026

• Metabolomic Characterization of Neonates Born to Hyperthyroid Mothers.

  Biomed Chromatogr, Mar 2026

• Research on Material Basis for the Nourishing Kidney Yin Effect of Dendrobium fimbriatum Hook.

  Biomed Chromatogr, Feb 2026

• Integrated multi-platform metabolomics reveals fatty acid-mediated inflammatory signatures in pretibial myxedema.

  Front Endocrinol (Lausanne), Jan 2026

• N-phenethylacetamide, diaminopimelic acid, and Gly-Val as high-performance serum biomarkers for diagnosing untreated Graves' disease: an LC-MS-based metabolomics study.

  Front Endocrinol (Lausanne), Nov 2025

• Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy.

  PLoS One, Jun 2024

• Iodine-131 intervention in hyperthyroidism with hepatic insufficiency: Metabolomic evaluation.

  Biomed Pharmacother, Mar 2024

See which targets of this disease your abstract mentions, and go to the people working on them.